Effects of Use Notification Policy for Various Classes of Antimicrobial Agents on Consumption of Antimicrobial Agents and Antimicrobial Resistance

Japanese Journal of Environmental Infections

Volumn 23, Issue 5, 2008, Pages 361-365

  Tanaka, Dai ^a   Fukasawa, Suzuko ^a   Kiko, Yasuhiro ^c   Kinoshita, Kaori ^a   Sakaguchi, Mikiyo ^a   Fujie, Toshihide ^b  

^a Department of Pharmacy ^*  (Japan)

^b Toshiba General Hospital   (Japan)

^c Fujisawa City Hospital   (Japan)

Author keywords

antimicrobial resistance; appropriate use; notification policy

Indexed keywords

EID: 84883381278     PISSN: 1882532X     EISSN: 18832407     Source Type: Journal    
DOI: 10.4058/jsei.23.361     Document Type: Article

References (6)

1. Takeyama K., Kunishima Y., Matsukawa M., Takahashi S., Hirose T., Kobayashi N., et al.: Multidrug-resistant Pseudomonas aeruginosa isolated from the urine of patients with urinary tract infection. J Infect Chemother 2002; 8(1): 59–63.
2. Toleman M.A., Biedenbach D., Bennett D.M., Jones R.N., Walsh T.R.: Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J Antimicrob Chemother 2005; 55 (1): 61–70.
3. Bronzwaer S.L., Cars O., Buehholz U., Molstad S., Goettsch W., Veldhuizen I.K., et al.: A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8(3): 278–282.
4. Lepper P.M., Grusa E., Reichl H., Hogel J., Trautmann M.: Consumption of imipenem correlates with b-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46(9): 2920–2925.
5. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd/.
6. Clinical and Laboratory Standards Institute (CLSI) : Performance standards for antimicrobial susceptibility testing. 16th informational supplement. Approved standard, CLSI document M100·S16, CLSI, 2006.